Search Results

There are 2536641 results for: content related to: Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists

  1. Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations

    Movement Disorders

    Volume 16, Issue 5, September 2001, Pages: 858–866, William Koller, Andrew Lees, Miroslava Doder, Mariese Hely and the Tolcapone/Pergolide Study Group

    Article first published online : 20 SEP 2001, DOI: 10.1002/mds.1175

  2. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

    Movement Disorders

    Volume 21, Issue 3, March 2006, Pages: 343–353, Wolfgang H. Oertel, Erik Wolters, Cristina Sampaio, Santiago Gimenez-Roldan, Bruno Bergamasco, Max Dujardin, Donald G. Grosset, Guy Arnold, Klaus L. Leenders, Hans-Peter Hundemer, Alberto Lledó, Andrew Wood, Paul Frewer and Johannes Schwarz

    Article first published online : 6 OCT 2005, DOI: 10.1002/mds.20724

  3. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists

    Movement Disorders

    Volume 21, Issue 8, August 2006, Pages: 1261–1264, Ji-Youn Kim, Eun Joo Chung, Seung Woo Park and Won Yong Lee

    Article first published online : 9 MAY 2006, DOI: 10.1002/mds.20931

  4. Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic study

    Movement Disorders

    Volume 21, Issue 8, August 2006, Pages: 1109–1113, Cecilia Peralta, Elisabeth Wolf, Hannes Alber, Klaus Seppi, Silvana Müller, Sylvia Bösch, Gregor K. Wenning, Otmar Pachinger and Werner Poewe

    Article first published online : 18 APR 2006, DOI: 10.1002/mds.20887

  5. Dopamine agonists for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 MAR 2011, DOI: 10.1002/14651858.CD006009.pub2

  6. You have free access to this content
    Treatment of restless legs syndrome: An evidence-based review and implications for clinical practice

    Movement Disorders

    Volume 23, Issue 16, 15 December 2008, Pages: 2267–2302, Claudia Trenkwalder, Wayne A. Hening, Pasquale Montagna, Wolfgang H. Oertel, Richard P. Allen, Arthur S. Walters, Joao Costa, Karin Stiasny-Kolster and Cristina Sampaio

    Article first published online : 16 OCT 2008, DOI: 10.1002/mds.22254

  7. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Article first published online : 21 OCT 2011, DOI: 10.1002/mds.23829

  8. Diagnosis and management of pergolide-induced fibrosis

    Movement Disorders

    Volume 19, Issue 6, June 2004, Pages: 699–704, Pinky Agarwal, Stanley Fahn and Steven J. Frucht

    Article first published online : 19 MAY 2004, DOI: 10.1002/mds.20200

  9. Pergolide Mesylate for Cocaine Abuse: A Controlled Preliminary Trial

    The American Journal on Addictions

    Volume 8, Issue 2, Spring 1999, Pages: 120–127, Frances R. Levin, David McDowell, Suzette M. Evans, Daniel Brooks, Christina Spano and Edward V. Nunes

    Article first published online : 18 FEB 2010, DOI: 10.1080/105504999305929

  10. Pergolide for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    C E Clarke and Julie Speller

    Published Online : 26 APR 1999, DOI: 10.1002/14651858.CD000235

  11. Bromocriptine use and the risk of valvular heart disease

    Movement Disorders

    Volume 24, Issue 3, 15 February 2009, Pages: 344–349, Louis C.S. Tan, Kenneth K.C. Ng, Wing-Lok Au, Raymond K.K. Lee, Yiong-Huak Chan and Nigel C.K. Tan

    Article first published online : 6 NOV 2008, DOI: 10.1002/mds.22228

  12. Meta-analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists

    Movement Disorders

    Volume 22, Issue 13, 15 October 2007, Pages: 1936–1942, Gregor Simonis, Joerg T. Fuhrmann and Ruth H. Strasser

    Article first published online : 20 JUL 2007, DOI: 10.1002/mds.21639

  13. You have free access to this content
    Dopamine depletion and subsequent treatment with l-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum

    Journal of Neurochemistry

    Volume 102, Issue 3, August 2007, Pages: 699–711, Evgeny Bychkov, M. Rafiuddin Ahmed, Kevin N. Dalby and Eugenia V. Gurevich

    Article first published online : 21 MAR 2007, DOI: 10.1111/j.1471-4159.2007.04586.x

  14. Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor

    Movement Disorders

    Volume 18, Issue 11, November 2003, Pages: 1324–1331, Prithiva Navan, Leslie J. Findley, Jim A.R. Jeffs, Ronald K.B. Pearce and Peter G. Bain

    Article first published online : 12 AUG 2003, DOI: 10.1002/mds.10538

  15. You have free access to this content
    High-sensitivity quantitation of cabergoline and pergolide using a triple-quadrupole mass spectrometer with enhanced mass-resolution capabilities

    Journal of Mass Spectrometry

    Volume 38, Issue 7, July 2003, Pages: 743–751, Nicola Hughes, Witold Winnik, Jean-Jacques Dunyach, Ma'an Amad, Maurizio Splendore and Gary Paul

    Article first published online : 15 JUL 2003, DOI: 10.1002/jms.489

  16. Awareness of potential valvulopathy risk with pergolide and changes in clinical practice after label change: a survey among European neurologists

    European Journal of Neurology

    Volume 14, Issue 6, June 2007, Pages: 644–649, A. LLedó, M. A. Dellva, I. M. Strombom, J. L. Wilkie, Mark E. Jungemann, M. G. Royer, V. E. Simmons and P. A. Cavazzoni

    Article first published online : 29 MAY 2007, DOI: 10.1111/j.1468-1331.2007.01801.x

  17. The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists

    Movement Disorders

    Volume 26, Issue 5, April 2011, Pages: 801–806, Vibeke Guldbrand Rasmussen, Karen Østergaard, Erik Dupont and Steen Hvitfeldt Poulsen

    Article first published online : 24 JAN 2011, DOI: 10.1002/mds.23470

  18. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S42–S80, Klaus Seppi, Daniel Weintraub, Miguel Coelho, Santiago Perez-Lloret, Susan H. Fox, Regina Katzenschlager, Eva-Maria Hametner, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Article first published online : 21 OCT 2011, DOI: 10.1002/mds.23884

  19. A Comparison of Pergolide and Bromocriptine in the Initial Rehabilitation of Cocaine Dependence

    The American Journal on Addictions

    Volume 3, Issue 2, Spring 1994, Pages: 144–150, Robert Malcolm, Joem D. Phillips, Kathleen T. Brady and John R. Roberts

    Article first published online : 18 FEB 2010, DOI: 10.1111/j.1521-0391.1994.tb00381.x

  20. A “combined” levodopa test as a useful method for evaluating the efficacy of dopamine agonists: Application to pergolide and bromocriptine

    Movement Disorders

    Volume 10, Issue 5, September 1995, Pages: 668–671, Dr. A. M. Bonnet, I. Serre, R. Marconi, Y. Agid and B. Dubois

    Article first published online : 12 OCT 2004, DOI: 10.1002/mds.870100522